Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting.
Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting.
复制标题
DOI:
10.4161/onci.22197
复制
发表时间:
2013-01-01
期刊:
影响因子:
7.2
通讯作者:
Mimura K
中科院分区:
文献类型:
--
作者:
Kono K;Mimura K
Although it has been shown in murine models that chemoradiotherapy may induce immunogenic tumor cell death, which could trigger T-cell immunity upon the released of high-mobility group box 1 protein (HMGB1), whether this also occurs in clinical settings remains unclear. Here, we discuss tumor-antigen specific T-cell responses in esophageal cancer patients receiving chemoradiotherapy. Our findings indicate that chemoradiation induces tumor antigen-specific T-cell responses and that the release of HMGB1 is related to clinical outcome.
登录
查看更多内容
影响因子:
5.7
作者:
Kono, Koji;Mizukami, Yoshiki;Fujii, Hideki
通讯作者:
Fujii, Hideki
影响因子:
8
作者:
Tesniere, A.;Schlemmer, F.;Kroemer, G.
通讯作者:
Kroemer, G.
影响因子:
11.5
作者:
Zitvogel, Laurence;Kepp, Oliver;Kroemer, Guido
通讯作者:
Kroemer, Guido
影响因子:
82.9
作者:
Apetoh, Lionel;Ghiringhelli, Francois;Zitvogel, Laurence
通讯作者:
Zitvogel, Laurence
影响因子:
82.9
作者:
Obeid, Michel;Tesniere, Antoine;Kroemer, Guido
通讯作者:
Kroemer, Guido